AzTrials
AzTrials

Laparoscopic CholecystectomyPhase 4NCT05021822

The Effect of Erector Spinae Block on Diaphragma Movement

A Phase 4 study testing Erector spinae plane block in people with Laparoscopic Cholecystectomy and Acute Post-operative Pain, run by Ufuk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Laparoscopic cholecystectomy surgeries cause moderate/severe pain and thus can result in shallow breathing, atelectasis and increased opioid consumption in the early postoperative period which in turn cause a longer hospital stay. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Erector spinae plane block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Aug 2021to 18 Sep 2021
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ages between 18 and 65
  • Patients in American Society of Anesthesiologists Classification I or II
  • Elective laparoscopic cholecystectomy surgery performed under general anesthesia

Who cannot join

  • Patient refusal
  • Patients who can not provide informed consent or with a known psychiatric disease
  • Patients with a known allergy to study drugs
  • Patients using anticoagulants and corticosteroids
  • Patients with diaphragma hernia, chronic obstructive pulmonary disease, lung cancer
  • Patients who are not able to use a patient controlled analgesia device

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ufuk Üniversitesi Dr. Rıdvan Ege Hastanesi

    Ankara, 06520

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Erector Spinae Plane Block on Diaphragma Movement in Laparoscopic Cholecystectomies

Laparoscopic cholecystectomy surgeries cause moderate/severe pain and thus can result in shallow breathing, atelectasis and increased opioid consumption in the early postoperative period which in turn cause a longer hospital stay. Erector spinae plane block has been shown to decrease lower thoracic pain after laparoscopic cholecystectomy surgeries. This study aims to investigate the effect of erector spinae plane block on opioid consumption and diaphragma movement after laparoscopic cholecystectomy surgeries.

Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Erector spinae plane blockProcedure or surgery

    Bilateral erector spinae plane block will be performed preoperatively under ultrasound guidance using 15 ml bupivacaine on each side

Study groups in NCT05021822
Study groupRoleWhat they receive
Block GroupActive comparatorNot described
Receives: Procedure: Erector spinae plane block
Control GroupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of Diaphragma excursion

    The change of diaphragma excursion as measured by ultrasound in M-mode from the preoperative period to the postoperative period

    Measured: Preoperative measurement-before the erector spina plane block application and postoperative measurement- 30 minutes after extubation

  2. Change in Opioid consumption

    To assess Tramadol consumption measured in mg postoperatively in the first 12 hours after the operation

    Measured: Postoperative 12 hours: in the first 30 minutes after extubation, 1st hour, 6th hour and 12th hour

  3. Change in postoperative pain

    Postoperative pain will be measured with visual analog scale and numeric scale in the first 12 hours after the operation

    Measured: Postoperative 12 hours: in the first 30 minutes after extubation, 1st hour, 6th hour and 12th hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2021
  2. Study start26 Aug 2021
  3. Primary completion18 Sep 2021
  4. Study completion18 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05021822
Sponsor's protocol ID
2021-03
Status last verified
Aug 2022
First submitted
13 Aug 2021
Last updated
10 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Petsas D, Pogiatzi V, Galatidis T, Drogouti M, Sofianou I, Michail A, Chatzis I, Donas G. Erector spinae plane block for postoperative analgesia in laparoscopic cholecystectomy: a case report. J Pain Res. 2018 Sep 24;11:1983-1990. doi: 10.2147/JPR.S164489. eCollection 2018.

    PubMed 30288093
  • Tulgar S, Kapakli MS, Senturk O, Selvi O, Serifsoy TE, Ozer Z. Evaluation of ultrasound-guided erector spinae plane block for postoperative analgesia in laparoscopic cholecystectomy: A prospective, randomized, controlled clinical trial. J Clin Anesth. 2018 Sep;49:101-106. doi: 10.1016/j.jclinane.2018.06.019. Epub 2018 Jun 15.

    PubMed 29913392

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Erector spinae plane block in people with Laparoscopic Cholecystectomy and Acute Post-operative Pain, run by Ufuk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of Diaphragma excursion (time frame: Preoperative measurement-before the erector spina plane block application and postoperative measurement- 30 minutes after extubation). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05021822, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in